ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Cardiovascular disease"

  • Abstract Number: 983 • 2016 ACR/ARHP Annual Meeting

    Objectively Assessed Sedentary Behaviour and Light Physical Activity Are Associated with Long-Term Cardiovascular Risk in People Living with Rheumatoid Arthritis Independently of Moderate-to-Vigorous Physical Activity

    Sally Fenton1,2, Jet Veldhuijzen van Zanten2,3, George D. Kitas2,4, Joan Duda4, Peter Rouse5, Chen-an Yu1 and George Metsios2,6, 1School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham, United Kingdom, 2Department of Rheumatology, Russells Hall Hospital, Dudley Group of Hospitals NHS Foundation Trust, Dudley, United Kingdom, 3University of Birmingham, Birmingham, United Kingdom, 4School of Sport, Exercise and Rehabilitation, University of Birmingham, Birmingham, United Kingdom, 5Department for Health, University of Bath, Bath, United Kingdom, 6Department of Physical Activity Exercise and Health, University of Wolverhampton, Walsall, United Kingdom

      Background/Purpose: Rheumatoid Arthritis (RA) can result in functional disability and is associated with an increased risk of cardiovascular disease (CVD). In healthy adults and…
  • Abstract Number: 1487 • 2016 ACR/ARHP Annual Meeting

    Comparison Between Intima-Media Thickness and Coronary Artery Tomography in Subclinical Atheroesclerosis Detection in Rheumatoid Arthritis

    Carlos Fernández-Díaz1, Lucia Cristina Domínguez-Casas1, Leyre Riancho-Zarrabeitia1, Alfonso Corrales1, José Antonio Parra2, Virginia Portilla3, Montserrat Santos-Gómez4, Patrick H Dessein5, Ricardo Blanco1 and Miguel Angel Gonzalez-Gay1, 1Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Santander, Spain, 2Radiology Division, Hospital Universitario Marqués de Valdecilla. IDIVAL, Santander, Spain, 3Hospital Universitario Marqués de Valdecilla. IDIVAL, Santander, Spain, 4Rheumatology, Hospital Can Misses, Ibiza, Spain, 5Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

    Background/Purpose:   Intima media thickness (IMT) and coronary artery calcification (CAC) quantification using multidetector computed tomography (MDCT) scanner are useful in detecting subclinical atherosclerosis and…
  • Abstract Number: 2160 • 2016 ACR/ARHP Annual Meeting

    Allopurinol Use and the Risk of Acute Cardiovascular Events in Patients with Gout and Diabetes

    Jasvinder A. Singh1, Rekha Ramachandaran2 and Jeffrey Curtis3, 1Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 2University of Alabama at Birmingham, Birmingham, AL, 3Division Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: To examine the effect of allopurinol on the risk of incident myocardial infarction (MI) or stroke in patients with gout and diabetes Methods: We…
  • Abstract Number: 3072 • 2016 ACR/ARHP Annual Meeting

    Increased Platelet Reactivity in Gout: Relationship to Tophus Burden and Colchicine Use

    Richard Conway1, Claire-Louise Murphy2, Anne Madigan3, Patricia Kavanagh4, Liz Geraghty3, Niamh Redmond5, Laura Helbert6, John J. Carey7, Eimear Dunne8, Dermot Kenny8 and Geraldine M. McCarthy9, 1CARD Newman Research Fellow, University College Dublin, Dublin, Ireland, 2Rayne Institute, Centre for Rheumatology Research, UCL Division of Medicine, London, United Kingdom, 3Rheumatology, Mater Misericordiae University Hospital, Dublin 7, Ireland, 4Rheumatology Department, Mater Public Hospital, Dublin 7, Ireland, 5UCD Clinical Research Centre, Dublin, Ireland, 6Rheumatology, Mater Misericordiae University Hospital, Dublin, Ireland, 7Rheumatology, Galway University Hospitals, Galway, Ireland, 8Molecular and Cellular Therapeutics, RCSI, Dublin 2, Ireland, 9Div of Rheumatology, Mater Misericordiae University Hospital, Dublin, Ireland

    Background/Purpose: Patients with gout have an increased risk of cardiovascular events. The presence of tophi is associated with enhanced cardiovascular risk. Increased platelet reactivity is…
  • Abstract Number: 523 • 2016 ACR/ARHP Annual Meeting

    Mortality Profile of Patients with Rheumatoid Arthritis in France and Its Change in 10 Years

    Jerome Avouac1, Fazia Amrouche2, Christophe Meune3, Grégoire Rey4, Andre Kahan5 and Yannick Allanore6, 1Rheumatology A department and INSERM U1016, Paris Descartes University, Cochin Hospital, Paris, France, 2Paris Descartes University, Cochin Hospital, Paris, France, 3Cardiology department, Université Paris XIII, Hôpitaux Universitaires Paris-Seine-Saint-Denis, Bobigny, France, 4Inserm-CépiDc, Hospital Bicêtre, Le Kremlin-Bicêtre, France, 5Service de Rhumatologie A, Hopital Cochin, Paris Cedex 14, France, 6Rheumatology, Paris Descartes University, Paris, France

    Background/Purpose: Rheumatoid arthritis (RA) is associated with an excess of mortality. This risk depends on the disease activity, severity and associated comorbidities. Our objective was…
  • Abstract Number: 1230 • 2016 ACR/ARHP Annual Meeting

    Allopurinol Use and the Risk of Stroke in the Elderly

    Jasvinder A. Singh1 and Shaohua Yu2, 1Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 2University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: To assess the effect of allopurinol use on the risk of stroke in the elderly Methods: We used the 5% random sample of Medicare…
  • Abstract Number: 1488 • 2016 ACR/ARHP Annual Meeting

    Comparison Between Carotid Ultrasonography and Coronary Artery Calcification Score to Detect Subclinical Atherosclerosis in Rheumatoid Arthritis

    Lucia Cristina Domínguez-Casas1, Leyre Riancho-Zarrabeitia1, Carlos Fernández-Díaz1, Nuria Vegas-Revenga2, Alfonso Corrales1, José Antonio Parra3, Montserrat Santos-Gómez4, Virginia Portilla2, Patrick H Dessein5, Ricardo Blanco1 and Miguel Angel Gonzalez-Gay1, 1Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Santander, Spain, 2Hospital Universitario Marqués de Valdecilla. IDIVAL, Santander, Spain, 3Radiology Division, Hospital Universitario Marqués de Valdecilla. IDIVAL, Santander, Spain, 4Rheumatology, Hospital Can Misses, Ibiza, Spain, 5Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

    Background/Purpose:   Carotid ultrasonography (CU) and coronary artery calcification score (CAC) evaluated by multidetector computed tomography (MDCT) scanner are useful in detecting subclinical atherosclerosis in…
  • Abstract Number: 2169 • 2016 ACR/ARHP Annual Meeting

    Presence of Cardiovascular Risk Factors Across Different Inflammatory Joint Disease Entities: Results from a Norwegian, Multi-Centre Project

    Grunde Wibetoe1, Eirik Ikdahl2, Silvia Rollefstad2, Anne Salberg3, Dag Magnar Soldal4, Tore K Kvien5, Glenn Haugeberg6 and Anne Grete Semb7, 1Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 2Diakonhjemmet Hospital, Oslo, Norway, 3Hospital for Rheumatic Diseases, Lillehammer, Norway, 4Rheumatology, Hospital of Southern Norway, Kristiansand, Norway, 5Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 6Martina Hansens Hospital, Bærum, Norway, 7Preventive Cardio-Rheuma clinic, Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway

    Background/Purpose: EULAR recommendations for cardiovascular disease (CVD) risk management in inflammatory joint diseases (IJD) advocates annual CVD risk assessments to reduce the increased CVD risk.…
  • Abstract Number: 3101 • 2016 ACR/ARHP Annual Meeting

    Lipoprotein Profile and Serum Glycoprotein Acetylation As Markers of Cardiovascular Risk in Systemic Lupus Erythematosus

    Simantini Sakhardande1, Monica Purmalek1, Yenealem Temesgen-Oyelakin2, Maureen Sampson3, Aditya Joshi4, Alice Fike5, Michael Davis6, Taufiq Salahuddin7, Balaji Natarajan7, Joseph Lerman7, Zerai G. Manna8, Amit Dey9, Marcus Chen7, Sarfaraz Hasni8, Nehal N. Mehta7, Alan Remaley7 and Mariana Kaplan10, 1Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 2National Institute of Arthritis and Musculoskeletal and Skin Diseases,, National Institutes of Health, Bethesda, MD, 3Department of Laboratory Medicine, National Institutes of Health, Bethesda, MD, 4National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, 5National Institutes of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 6NIH, Bethesda, MD, 7NHLBI, National Institutes of Health, Bethesda, MD, 8National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 9National Institutes of Health, Bethesda, MD, 10NIAMS/NIH, Bethesda, MD

    Background/Purpose:  The risk of atherosclerotic cardiovascular disease (CVD) is significantly increased in systemic SLE compared to age and gender matched controls. The implementation of nuclear…
  • Abstract Number: 524 • 2016 ACR/ARHP Annual Meeting

    A Self-Determination Theory Based Intervention to Increase Levels of Cardiorespiratory Fitness, Self-Determined Motivation, Physical Activity and Improve Health Outcomes Among Patients Living with Rheumatoid Arthritis

    Joan Duda1, Sally Fenton1,2, Jet Veldhuijzen van Zanten2,3, George Metsios2,4, Peter Rouse5, Nikos Ntoumanis6, Chen-an Yu7, Yiannis Koutedakis8 and George D. Kitas1,2, 1School of Sport, Exercise and Rehabilitation, University of Birmingham, Birmingham, United Kingdom, 2Department of Rheumatology, Russells Hall Hospital, Dudley Group of Hospitals NHS Foundation Trust, Dudley, United Kingdom, 3University of Birmingham, Birmingham, United Kingdom, 4Department of Physical Activity Exercise and Health, University of Wolverhampton, Walsall, United Kingdom, 5Department for Health, University of Bath, Bath, United Kingdom, 6School of Psychology & Speech Pathology, Curtin University, Perth, Australia, 7School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham, United Kingdom, 8University of Wolverhampton, Wolverhampton, United Kingdom

    Background/Purpose: Rheumatoid arthritis (RA) may cause joint damage leading to physical dysfunction and associates with increased cardiovascular (CV) risk. Regular physical activity (PA) can attenuate…
  • Abstract Number: 1447 • 2016 ACR/ARHP Annual Meeting

    Therapeutic Blockade of Interleukin-6 Trans-Signalling Restores Vascular Function in Murine Collagen Induced Arthritis

    Ruth Davies1, Jessica O Williams2, Katie Sime2, Ellyn Hughes2, Lauren A. Jordan2, Charlotte Rawlings2, Derek Lang3, Stefan Rose-John4, Simon A. Jones5, Anwen S. Williams2 and Ernest H. Choy6,7, 1CREATE Centre, Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom, 2Institute of Infection and Immunity, Cardiff University, Cardiff, United Kingdom, 3Institute of Molecular and Experimental Medicine, Cardiff University School of Medicine, Cardiff, United Kingdom, 4Institute of Biochemistry, Christian Albrechts University, Kiel, Germany, 5Infection, Immunity and Biochemistry, School of Medicine, Cardiff University, Cardiff, Wales, 6Section of Rheumatology, Cardiff University, Cardiff, Great Britain, 7CREATE Center, Division of Infection and Immunity,, Cardiff University, Cardiff, United Kingdom

    Background/Purpose: Mortality is increased in rheumatoid arthritis (RA), mainly due to cardiovascular disease (CVD). While molecular mechanisms underlining this clinical observation are unknown, systemic elevations…
  • Abstract Number: 1490 • 2016 ACR/ARHP Annual Meeting

    Metabolic and Cardio-Vascular Benefits of Hydroxychloroquine in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

    Claire Rempenault1, Thomas Barnetche2, Jacques Morel3, Cédric Lukas4, Cécile Gaujoux-Viala5, Bernard Combe6 and Charlotte Hua7, 1Rheumatology, CHU Lapeyronie, University of Montpellier, France, 2Rheumatology Department, Pellegrin University Hospital, BORDEAUX, France, 3Rheumatology, Department of Rheumatology, Montpellier University Hospital, Montpellier, France, 4Rheumatology, CHU Lapeyronie and EA2415, Montpellier University, University of Montpellier, France, 5Rheumatology Department, University Hospital of Nîmes and EA2415, Montpellier University, Nîmes, France, 6Département Rhumatologie, Hôpital Lapeyronie, Montpellier, France, 7Department of Rheumatology, Lapeyronie Hospital and Montpellier University, Montpellier, France

    Background/Purpose: Cardiovascular disease (CVD) is the leading cause of mortality in rheumatoid arthritis (RA) patients. Hydroxychloroquine (HCQ) has been shown to improve major outcomes like…
  • Abstract Number: 2170 • 2016 ACR/ARHP Annual Meeting

    Cardiovascular Risk in Patients with Psoriasis, Psoriatic and Rheumatoid Arthritis: A Prospective Study Using Secured Anonymised Information Technology Databank in Wales, United Kingdom

    Ernest H. Choy1, Roxanne Cooksey2, Sinead Brophy2, Jonathan Kennedy2, Fabiola Fernandez-Gutierrez3, Ruth Davies4, Timothy Pickles5 and Vincent Piguet6, 1CREATE Center, Division of Infection and Immunity,, Cardiff University, Cardiff, United Kingdom, 2College of Medicine, Swansea University, Swansea, United Kingdom, 3Cancer Research UK Manchester Institute, Manchester, United Kingdom, 4CREATE Centre, Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom, 5CREATE Center, Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom, 6Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom

    Background/Purpose: Compared with cardiovascular (CV) risk in rheumatoid arthritis (RA), precise CV risk in psoriatic arthritis (PsA) and psoriasis is less established, particularly the relative…
  • Abstract Number: 3103 • 2016 ACR/ARHP Annual Meeting

    Apolipoprotein L1 Risk Variants Associate with Prevalent Cardiovascular Disease in African American Systemic Lupus Erythematous Patients

    Ashira Blazer1, Robert M Clancy2, H. Michael Belmont3, Peter M. Izmirly3, Androo Markham4 and Jill P. Buyon4, 1Division of Rheumatology, NYU School of Medicine, New York, NY, 2Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, 3New York University School of Medicine, New York, NY, 4Medicine, New York University School of Medicine, New York, NY

    Background/Purpose:  Two Apolipoprotein L1 (APOL1) risk variants (RV), G1 and G2, located on chromosome 22q12.3, have been associated with excess renal risk in African Americans…
  • Abstract Number: 563 • 2016 ACR/ARHP Annual Meeting

    Factors Associated with Cognitive Impairment in Korean Adults with Rheumatoid Arthritis

    So Young Shin1, Joo Hyun Lee2 and Bo Young Yoon3, 1Department of Nursing, Inje University, College of Medicine, Department of Nursing, Busan, Korea, The Republic of, 2Rheumatology/Internal medicine, Inje University Ilsan Paik Hospital, Goyang, Korea, The Republic of, 3Rheumatology/Internal medicine, Inje Iniversity Ilsan Paik Hospital, Goyang, Korea, The Republic of

    Background/Purpose:  For persons with chronic diseases such as rheumatoid arthritis (RA), intact cognitive function is crucial for performing main daily activities and adhering to self-management…
  • « Previous Page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • …
  • 38
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology